Concepta PLC myLotus Fertility Product - China Update (6229T)
16 October 2017 - 5:00PM
UK Regulatory
TIDMCPT
RNS Number : 6229T
Concepta PLC
16 October 2017
16 October 2017
Concepta plc ("Concepta" or the "Company")
myLotus Fertility Product - China Update
Concepta plc (AIM: CPT), the pioneering UK healthcare company
and developer of a proprietary platform and suite of products
targeted at the personalised mobile health market with a primary
focus on women's fertility and specifically unexplained
infertility, is pleased to announce a positive update on the launch
of its proprietary myLotus product in its first international
market, China.
Distribution Agreements
The Company has signed an additional two 3-year exclusive
distribution agreements for its myLotus fertility product with
Huanzhong Biotech Ltd and Wanma Technology Co., Ltd in China.
The distribution agreement with Huanzhong Biotech Ltd will cover
the province of Hebei near Beijing, while Wanma Technology Co., Ltd
will cover the Shanghai area. Alongside ThinkBrio, which
distributes the myLotus product to Beijing and Lianoing, these two
agreements will expand Concepta's product offering in China to
target a total population of 147 million people across these
regions.
Dr Yin Hui Rong, principal investigator at the Changhai Hospital
Reproductive Centre,commented on the Company's myLotus product: "I
have been impressed with the performance of myLotus. This small,
hand-held device is providing results that are comparable to large
laboratory equipment. It opens up the opportunity for more
flexibility in large and smaller hospitals but also for the women
at home."
Hospital evaluation results
Concepta has completed a preliminary hospital evaluation process
in China to extend the use of the Company's myLotus product into
early pregnancy monitoring. Based on recent positive hospital
evaluation results, the Company's new distributors, Huanzhong
Biotech Ltd and Wanma Technology will be the first to target the
'early pregnancy' group alongside the 'unexplained infertility'
target group. There is a total target market of 2.3 million women a
year across the Hebei, Beijing, Lianoing and Shanghai areas for
early pregnancy monitoring.
Erik Henau, CEO commenting on the Company's hospital evaluation
and new distribution agreements said: "We are delighted to add
these new distributors to our network in China, following the
Company's excellent preliminary hospital evaluation results.
Following the final conclusion of the evaluation, an event will be
held in China for a large number of potential distributors where we
will exhibit the myLotus product. We expect to announce further
distribution agreement signings following this event."
Collaboration with The British Bid
The Company is also pleased to announce the publication of a
corporate video, which was broadcast on the BBC World Service on 26
September 2017 and is now available to view online.
myLotus addresses fertility issues that are prevalent throughout
the world. Whilst focused on its initial launch in China, Concepta
will be able to raise its international profile in collaboration
with The British Bid, a global initiative designed to demonstrate
the best in British business to ultimately generate new growth via
overseas trade. It provides British businesses with a platform to
be a voice of excellence for their industry across the globe.
From outside of the UK, the corporate video made in
collaboration with The British Bid is now available to watch on
BBC.com (http://www.bbc.com/storyworks/the-british-bid/concepta),
while from the U.K., it is available to watch on Concepta's
website: www.conceptaplc.com
Eric Henau commented: "To realise the potential of the unique
myLotus product requires organic growth as well as collaborative
deals. Initiatives such as The British Bid are invaluable for
attracting potential partners which can aid the Company's organic
growth as it continues to develop its myLotus product."
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have
been deemed inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 until the release of this
announcement.
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 7557 985 479
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin / Mark Brady
Tel: +44 (0)20 368 3550
Beaufort Securities Limited (Broker)
Jon Belliss
Tel: +44 (0)20 7382 8300
Yellow Jersey (Financial PR)
Felicity Winkles / Joe Burgess / Katie Bairsto
Tel: +44 (0) 776 932 5254
About Concepta Plc:
Concepta plc is a pioneering UK healthcare company that has
developed a proprietary platform and products targeted at the
personalised mobile health market with a primary focus on women's
fertility and specifically unexplained infertility*.
Founded in 2013, Concepta has developed a revolutionary flagship
product 'MyLotus' for home self-testing that helps women with
unexplained infertility to conceive.
MyLotus is the only consumer product which allows both
quantitative and qualitative measurements of measurement of a
woman's personal hCG and LH hormone levels in an easy to use home
test to facilitate higher conception rates and early diagnosis of
any fertility problems. Competitor products currently only allow
qualitative measurement and are based on the 'average woman'.
Concepta has a defined route to market for its new 'My Lotus'
product with Regulatory approvals for launch in China in place for
2016 and CE-Marking for UK and Europe to follow in 2017 where the
revenue potential of the Chinese and EU infertility market is worth
c.GBP600m per annum for the company.
*Unexplained infertility refers to women that have been unable
to conceive after 6 months of trying. This highly motivated target
group of consumers won't typically be offered medical intervention
until 12 months of unsuccessfully trying, with IVF not offered
until two years. Research indicates couples start to take positive
action ahead of this time and there is little medical support to
help them do so.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PRLOKPDPCBDKKKD
(END) Dow Jones Newswires
October 16, 2017 02:00 ET (06:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024